Alcon partners with actress Kate Walsh on US launch of Systane dry eye drops

Article

The partnership is in support of the company's latest dry eye relief campaign and part of the launch for its leading global artificial tear drop brand.

Kate Walsh

Image courtesy of Alcon

Alcon is partnering with actress Kate Walsh as part of the launch for its Systane Complete Preservative-Free Lubricant Eye Drops for the treatment of dry eye, the company announced Thursday.

As part of the Alcon’s new Make Every Look Count campaign, Walsh will share her personal experience with how dry eye has impacted her life and the positive effect the company’s dry eye product has had on relieving symptoms.

According to Walsh, the goal of the campaign is to encourage those with dry eye to find what works for their symptoms “so they can reconnect with loved ones and the experiences in life that matter most,” she said in a news release.

Systane Complete Preservative-Free Lubricant Eye Drops works by hydrating and supporting all layers of the tear film, providing 8 hours of relief for dry eye symptoms after application of one drop.

Intelligent moisture and lipid delivery is used to enhance dispersion across the surface of the eye to stabilize the tear film, the company stated.

Its nano-droplet technology allows for fast-acting hydration, tear evaporation protection, and long-lasting relief for a patient’s eyes.

The bottle’s closing tip system was designed using patented PureFlow technology to ensure safe delivery of the artificial tear.

It has a one-way valve so no contaminated liquid is re-introduced into the container after a drop has been dispensed, eliminating the need for preservatives in the eye drops.

The product was launched in Europe earlier this year, with plans to extend to Australia and additional markets later in 2022.

“The addition of Systane Complete Preservative-Free to our portfolio means we can expand options and deliver real, long-lasting relief to help people see brilliantly at a time when dry eye symptoms are on the rise,” said Sean Clark, general manager, US Vision Care at Alcon, in a statement.

See more dry eye coverage

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Recent Videos
Mitch Ibach, OD, FAAO, details the importance to unveiling the underlying cause of dry eye in a CCS 2025 presentation.
Bridgitte Shen Lee, OD, FAAO, FBCLA, FEAOO, ponders what she would like to see develop as both a researcher and a clinician in the dry eye space.
Bridgitte Shen Lee, OD, FAAO, FBCLA, FEAOO, discussed research that utilized IQVIA longitudinal prescription claims data from September through November 2023, coinciding with Miebo's FDA approval in September.
Dr Julie Poteet reports on patient-reported outcomes using lipid-containing artificial tear
Elise Kramer, OD, FAAO, FSLS, describes her take on a multidisciplinary approach to dry eye
Cecelia Koetting, OD, FAAO, DipABO, weighs in on patient assessments, staining pattern insights, and diagnostic tips for patients who may have dry eye disease.
Mile Brujic, OD, FAAO; Nate Lighthizer, OD, FAAO; Brianna Rhue, OD, FAAO, FSLS; Ben Casella, OD; and Ben Gaddie, OD, FAAO shared their insights from the conference.
Agatha Sleboda, OD; Arti Shah, OD, FAAO; and Kent J. Nozacki, OD provide the best tips that they give to their patients during natural disasters events in light of the recent Greater Los Angeles wildfires.
Dr. Nate Lighthizer shares key takeaways from the SECO Showcase on anterior segment technology and full laser certification course offered at SECO.
Dr Ben Gaddie chats about his dry eye presentation at SECO and ocular surface disease.jpg
© 2025 MJH Life Sciences

All rights reserved.